Hysterectomy Clinical Trials

Clinical trials related to Hysterectomy Procedure

Evaluation of Clinical Outcomes and Acceptability of an Anatomical Classification for Placenta Accreta

Status: Recruiting
Location: See location...
Intervention Type: Procedure
Study Type: Observational
SUMMARY

This study evaluates the clinical implementation of intra-operative topographic classification system for PAS. In addition to a standard of care risk stratification prenatal ultrasound for patients with a risk of PAS, this study adds an additional intraoperative surgical staging protocol to validate the classification system, improve surgical approach, and significantly clinical outcomes of pregnant people with an a prior risk of PAS. The study will involve pregnant patients with PAS risk factor, include data collection spanning prenatal assessment, intraoperative classification, surgical technique implementation and postoperative analysis. The anticipated study duration is approximately 36-48 months.

Eligibility
Participation Requirements
Sex: Female
Minimum Age: 18
Maximum Age: 55
Healthy Volunteers: f
View:

• Pregnant people suspected of having PAS based on ultrasound findings or clinical risk factors

• Patients undergoing planned surgical intervention for PAS, including a planned cesarean

• Individuals who provide informed consent to participate in the study

• Patients with at least one prenatal assessment before surgery

• Expected age range: 18-55

• Patient has agreed to conservative management approach as part of standard of care if feasible intraoperatively

Locations
United States
California
University of California, Los Angeles
RECRUITING
Los Angeles
Contact Information
Primary
Dana Levin-Lopez, MPH
dlevinlopez@mednet.ucla.edu
310-794-8893
Time Frame
Start Date: 2025-12-01
Estimated Completion Date: 2028-12-31
Participants
Target number of participants: 60
Treatments
PAS
Patients with placental accreta undergoing planned surgical intervention for PAS
Related Therapeutic Areas
Sponsors
Leads: University of California, Los Angeles

This content was sourced from clinicaltrials.gov